CarboneC., PiroG., TamburrinoA., MinaM. M., ZaniniS., TortoraG., & MelisiD. (2013). TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP. Journal of the Pancreas, 14(5S), 562. https://doi.org/10.6092/1590-8577/1866